๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
2,670.00
-215.00 (-7.45%)
Sep 6, 2026, 3:08 AM KST

GeneOne Life Science Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9,07123,04535,72040,20348,71838,700
Revenue Growth
-70.64%-35.48%-11.15%-17.48%25.89%-6.75%
Gross Profit
-15,831-15,217-10,967-7,8859,1778,642
Operating Income
-35,825-44,036-43,039-48,368-40,199-27,527
Net Income
-52,875-51,851-48,537-77,768-38,150-15,888
Earnings Per Share
-2925.06-3145.00-3055.00-5001.17-2461.75-1070.01
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fabric Business
11,07413,29312,74915,87814,344
Pharmaceutical Business
11,97022,42727,45432,84024,356
Total
23,04535,72040,20348,71838,700

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,8221,7351,7469,98845,603107,404
Total Debt
31,33232,95827,12617,16019,66618,400
Net Cash (Debt)
-25,510-31,223-25,379-7,17125,93789,004
Net Cash Growth
-----70.86%22.34%
Net Cash Per Share
-1410.62-1893.01-1597.03-461.181673.655994.19

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9,737-16,541-16,058-21,744-24,113-4,849
Capital Expenditures
-1,243-23.82-3,298-5,601-45,306-82,442
Free Cash Flow
-10,980-16,565-19,356-27,345-69,419-87,291
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-174.52%-66.03%-30.70%-19.61%18.84%22.33%
Operating Margin
-394.94%-191.09%-120.49%-120.31%-82.51%-71.13%
Pretax Margin
-584.01%-225.38%-136.49%-193.16%-78.11%-40.14%
Profit Margin
-582.90%-225.00%-135.88%-193.44%-78.31%-41.05%
FCF Margin
-121.05%-71.88%-54.19%-68.02%-142.49%-225.56%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.347.244.735.5311.3632.32